Journal ArticleDOI
Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Lena Dillner,Sonia Pagliusi,Freddie Bray,Attila T. Lorincz,Susanne K. Kjaer,Ahti Anttila,Ole Eric Iversen,Joakim Dillner,Matti Lehtinen,Jorma Paavonen +9 more
Reads0
Chats0
TLDR
The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally.Abstract:
Disease trend studies based on birth cohort analysis and serological studies indicate that recent generations have a higher prevalence of oncogenic Human Papilloma Virus (HPV) types, and are likely to be at higher risk of cancer than previous generations. This implies that prevention strategies to protect young populations from HPV-associated cancers need to be strengthened, and hence organized implementation of vaccination and better screening programs are being considered. In this context, randomized large-scale policy evaluations will be instrumental in accelerating disease control and improve effective prevention programs. This report shares experiences from Nordic countries with examples of prevention strategies through vaccination and cervical screening. The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally.read more
Citations
More filters
Journal ArticleDOI
Breast and cervical cancer screening programme implementation in 16 countries.
TL;DR: A programme assessment conducted within the International Cancer Screening Network (ICSN) to understand the characteristics of cervical screening programmes within countries that have established population-based breast cancer screening programmes is reported.
Journal ArticleDOI
Psychological burden of testing positive for high‐risk human papillomavirus on women with atypical cervical cytology: a prospective study
Tracy T. C. Kwan,Annie N.Y. Cheung,Sue S.T. Lo,Peter W. H. Lee,Kar Fai Tam,Karen K. L. Chan,Hextan Y.S. Ngan +6 more
TL;DR: A concurrent positive HPV result intensified the distress of women with ASCUS at result notification and with time and after colposcopy, their initial heightened anxiety and cervical cancer worry were significantly lowered, suggesting HPV positivity may pose a prolonged psychosocial burden on women even after having had the necessary follow‐up for their cervical abnormalities.
Journal ArticleDOI
Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
Christine Dimitrakaki,Dimitris Boulamatsis,Anargiros Mariolis,Nick Kontodimopoulos,Dimitris Niakas,Yannis Tountas +5 more
TL;DR: The percentage of the population in Greece receiving screening services recommended by the European Council is low and seriously affected by social factors, and public health policies should direct their efforts towards introducing good-quality universal cancer screening and find culturally sensitive ways of addressing the barriers that prevent Greek people from adopting poor-quality cancer screening practices.
Journal ArticleDOI
Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
Journal ArticleDOI
Effectiveness of Cervical Cancer Screening in Iceland, 1964–2002: A Study on Trends in Incidence and Mortality and the Effect of Risk Factors
TL;DR: Stage was the most powerful risk factor for death from cervical cancer followed by age, calendar time and, to a lesser degree, histology and the investigators propose that screening for cervical cancer begin before age 25 years and continue at 2- to 3-year intervals.
References
More filters
Journal ArticleDOI
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Jan M. M. Walboomers,M. V. Jacobs,M. M. Manos,Franz X. Bosch,J. A. Kummer,Keerti V. Shah,Peter J.F. Snijders,Julian Peto,Chris J.L.M. Meijer,Nubia Muñoz +9 more
TL;DR: The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer, and the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
Journal ArticleDOI
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
Nubia Muñoz,F. Xavier Bosch,Silvia de Sanjosé,Rolando Herrero,Xavier Castellsagué,Keerti V. Shah,Peter J.F. Snijders,Chris J.L.M. Meijer +7 more
TL;DR: In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82Should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.
Journal ArticleDOI
Estimates of the cancer incidence and mortality in Europe in 2006
TL;DR: The total number of new cases of cancer in Europe appears to have increased by 300,000 since 2004 and the ageing of the European population will cause these numbers to continue to increase even if age-specific rates remain constant.
Journal ArticleDOI
Estimates of cancer incidence and mortality in Europe in 2008.
TL;DR: The statistical models used used to estimate incidence and mortality data for 25 cancers in 40 European countries in 2008 used to obtain an estimate of the numbers of cancer cases and deaths in Europe in 2008.
Journal ArticleDOI
Estimates of cancer incidence and mortality in Europe in 1995
TL;DR: Cancer incidence and mortality estimates for 1995 are presented for the 38 countries in the four United Nations-defined areas of Europe, using World Health Organization mortality data and published estimates of incidence from national cancer registries to demonstrate the very substantial burden of cancer in Europe, and the scope for prevention.